Skip to main content
. 2026 Jan 6;37:102772. doi: 10.1016/j.mtbio.2026.102772

Fig. 8.

Fig. 8

Schematic diagram of nanomaterial design and specific mechanisms for PA imaging in RA treatment. (A) Immuno-modulating theranostic gold nanocages for the treatment of rheumatoid arthritis in vivo. Reprinted from Ref. [29]. Copyright 2022, Elsevier. (B) Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis. Reprinted from Ref. [30]. Copyright 2022, PANS. (C) Development of a Controllable Intelligent Drug Delivery System for Efficient Treatment of Rheumatoid Arthritis. Reprinted from Ref. [31]. Copyright 2024, American Chemical Society. (D) In vivo nano contrast-enhanced photoacoustic imaging for dynamically lightning the molecular changes of rheumatoid arthritis. Reprinted from Ref. [32]. Copyright 2021, Elsevier. (E) Inflammation-Responsive Nanoagents for Activatable Photoacoustic Molecular Imaging and Tandem Therapies in Rheumatoid Arthritis. Reprinted from Ref. [33]. Copyright 2024, American Chemical Society. (F) Tocilizumab-Conjugated Polymer Nanoparticles for NIR-II Photoacoustic-Imaging-Guided Therapy of Rheumatoid Arthritis. Reprinted from Ref. [34]. Copyright 2022, John Wiley and Sons. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)